To detect potential pathways and target genes in infantile Pompe patients using computational analysis

Aynur Karadağ Gürel ¹ * , Selçuk Gürel ²

Cited by CrossRef: 6

1- HEKMATSHOAR Y, KARADAĞ GÜREL A. Entegre miRNA/mRNA düzenleyici ağ analizi ile Glioblastomda temozolomid direnç faktörlerinin belirlenmesi. 2023;6(3):73 [Crossref]

2- Voskamp S, Hammonds M, Knapp T, Pekmezian A, Hadley D, Nelson J. Meta‐analysis reveals differential gene expression in tetralogy of Fallot versus controls. Birth Defects Research. 2024;116(1) [Crossref]

3- Hekmatshoar Y, Rahbar Saadat Y, Ozkan T, Bozkurt S, Karadag Gurel A. Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study. Nucleosides, Nucleotides & Nucleic Acids. 2024;43(7):664 [Crossref]

4- Zhang M, Niu J, Xu M, Wei E, Liu P, Sheng G. Interplay between mitochondrial dysfunction and lysosomal storage: challenges in genetic metabolic muscle diseases with a focus on infantile onset Pompe disease. Front Cardiovasc Med. 2024;11 [Crossref]

5- Hekmatshoar Y. The Impact of Olaparib on Metabolic Pathways in Triple Negative Breast Cancer: A Bioinformatics Approach. 2024;6(3):555 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons